HRS Late-Breakers: Registry Outcomes, ICD Programming, Placement Data
This article was originally published in The Gray Sheet
Presentations at the Heart Rhythm Society annual scientific sessions last week in Denver included data from a long-term registry and from studies measuring the impact of tweaking defibrillator therapy to improve outcomes
You may also be interested in...
Results of Medtronic's STOP AF trial show that 69.3% of patients treated with its Arctic Front cryoballoon catheter were free from atrial fibrillation at one year
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.